Skip to main content

Table 3 Quality appraisal of included studies using Newcastle-Ottawa Scale

From: A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections

Study (Author-Date) Representativeness Demonstration that outcome not present at outset Assessment of outcome (proven infection vs suspected infection based on other criteria) Adequacy of follow-up (<5% loss)
Alleyne 2000 [31] * * * *
Arabi 2005 [36] *    *
Bota 2005 [35] * * * *
Camacho 2011 [8] * *   *
Chi 2009 [24] * * * *
Dasic 2006 [10] *   * *
Fichtner 2010 [28] * *  
Hader 2000 [17] * * * *
Hoefnagel 2008 [2] * * *  
Holloway 1996 [25]    *
Khalil 2005 [9] * * * *
Kim 2012 [34] * * * *
Kitchen 2011 [6]    * *
Lemcke 2012 [20] * * * *
Leverstein Van-Dall 2010 [21] *    *
Lo 2007 [18] * *   *
Lundberg 2000 [16] * *  
Lwin 2012 [27] *   * *
Lyke 2001 [13] * * * *
Mahe 1995 [7] *    *
McLaughlin 2012 [19]     *
Moon 2007 [12] *   * *
Park 2004 [29] * * * *
Rafiq 2011 [15] * * * *
Rivero-Garvia 2011 [26] *    *
Roitberg 2001 [30]    *
Scheithauer 2009 [23] * *   *
Scheithauer 2010 [22] * *   *
Schodel 2012 [32] *   * *
Schultz 1993 [11] * * *
Sloffer 2005 [33]   * * *
Smigoc 2012 [5] * * *
Smith 1976 [4] *   *  
Williams 2011 [14] * * * *
Wyler 1972 [3] *   * *
  1. *Denotes that the quality criteria has been met.